
Rheumatoid arthritis drugs may save lives of patients hospitalized with severe cases of COVID-19, according to a groundbreaking clinical trial. The findings, first announced in January, have now been peer-reviewed and published in a major medical journal. “We are delighted that our full results are now published after peer review. This confirms the robustness of… read on > read on >